A Phase 2a Study to Evaluate the Effects of Sirukumab in Subjects With Severe Poorly Controlled Asthma
Clinical trial NCT02794519 · WITHDRAWN
Trial details
- NCT number
- NCT02794519
- Sponsor
- GlaxoSmithKline
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-23
- Primary completion
- 2016-10-04
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.